Aflibercept suppresses ovarian hyperstimulation syndrome: an experimental study in rats.

Çağlayan Ateş Berna Dilbaz Seval Yilmaz Ergani Fuad Atabay

Published in: Revista da Associacao Medica Brasileira (1992) (2023)

Aflibercept, an antiangiogenic medication, decreased ovarian hyperstimulation syndrome by lowering the vascular permeability and vascular endothelial growth factor expression.

Keyphrases

vascular endothelial growth factor
endothelial cells
poor prognosis
case report
emergency department
binding protein
adverse drug
long non coding rna
electronic health record